Radiation therapy for melanoma brain metastases: a systematic review

1de la Monte SD, Moore GW, Hutchins GM. Patterned distribution of metastases from malignant melanoma in humans. Cancer Res 1983; 43: 3427-33. PMID: 6850649 de la Monte SD Moore GW Hutchins GM Patterned distribution of metastases from malignant melanoma in humans Cancer Res 1983 43 3427 33 PMID: 6850649Search in Google Scholar

2Amer MH, Al-Sarraf M, Baker LH, Vaitkevicius VK. Malignant melanoma and central nervous system metastases. Incidence, diagnosis, treatment and survival. Cancer 1978; 42: 660-8. doi:10.1002/1097-0142(197808)42:2<660::AID-CNCR2820420237>3.0.CO;2-E Amer MH Al-Sarraf M Baker LH Vaitkevicius VK Malignant melanoma and central nervous system metastases Incidence, diagnosis, treatment and survival. Cancer 1978 42 660 8 10.1002/1097-0142(197808)42:2<660::AID-CNCR2820420237>3.0.CO;2-EOpen DOISearch in Google Scholar

3Zhang D, Wang Z, Shang D, Yu J, Yuan S. Incidence and prognosis of brain metastases in cutaneous melanoma patients: a population-based study. Melanoma Res 2019; 29: 77-84. doi: 10.1097/CMR.0000000000000538 Zhang D Wang Z Shang D Yu J Yuan S Incidence and prognosis of brain metastases in cutaneous melanoma patients: a population-based study Melanoma Res 2019 29 77 84 10.1097/CMR.0000000000000538Open DOISearch in Google Scholar

4Chukwueke U, Batchelor T, Brastianos P. Management of brain metastases in patients with melanoma. J Oncol Practice 2016; 12: 536-42. doi: 10.1200/JOP.2016.011882 Chukwueke U Batchelor T Brastianos P Management of brain metastases in patients with melanoma J Oncol Practice 2016 12 536 42 10.1200/JOP.2016.011882Open DOISearch in Google Scholar

5Raizer JJ, Hwu WJ, Panageas KS, Wilton A, Baldwin DE, Bailey E, et al. Brain and leptomeningeal metastases from cutaneous melanoma: survival outcomes based on clinical features. Neuro Oncol 2008; 10: 199-207. doi: 10.1215/15228517-2007-058 Raizer JJ Hwu WJ Panageas KS Wilton A Baldwin DE Bailey E et al Brain and leptomeningeal metastases from cutaneous melanoma: survival outcomes based on clinical features Neuro Oncol 2008 10 199 207 10.1215/15228517-2007-058Open DOISearch in Google Scholar

6Winston K, Walsh J, Fischer E. Results of operative treatment of intracranial metastatic tumors. Cancer 1980; 45: 2639-45. doi: 10.1002/1097-0142(19800515)45:10<2639::AID-CNCR2820451025>3.0.CO;2-O Winston K Walsh J Fischer E Results of operative treatment of intracranial metastatic tumors Cancer 1980 45 2639 45 10.1002/1097-0142(19800515)45:10<2639::AID-CNCR2820451025>3.0.CO;2-OOpen DOISearch in Google Scholar

7Pasquali S, Hadjinicolaou AV, Chiarion Sileni V, Rossi CR, Mocellin S. Systemic treatments for metastatic cutaneous melanoma. Cochrane Database Syst Rev 2018; 2: CD011123. doi: 10.1002/14651858.CD011123.pub2 Pasquali S Hadjinicolaou AV Chiarion Sileni V Rossi CR Mocellin S Systemic treatments for metastatic cutaneous melanoma Cochrane Database Syst Rev 2018 2 CD011123 10.1002/14651858.CD011123.pub2Open DOISearch in Google Scholar

8Hao C, Tian J, Liu H, Li F, Niu H, Zhu B. Efficacy and safety of anti-PD-1 and anti-PD-1 combined with anti-CTLA-4 immunotherapy to advanced melanoma: a systematic review and meta-analysis of randomized controlled trials. Medicine 2017; 96: e7325. doi: 10.1097/MD.0000000000007325 Hao C Tian J Liu H Li F Niu H Zhu B Efficacy and safety of anti-PD-1 and anti-PD-1 combined with anti-CTLA-4 immunotherapy to advanced melanoma: a systematic review and meta-analysis of randomized controlled trials Medicine 2017 96 e7325 10.1097/MD.0000000000007325Open DOISearch in Google Scholar

9Dequen P, Lorigan P, Jansen JP, van Baardewijk M, Ouwens MJ, Kotapati S. Systematic review and network meta-analysis of overall survival comparing 3 mg/kg ipilimumab with alternative therapies in the management of pretreated patients with unresectable stage III or IV melanoma. Oncologist 2012; 17: 1376-85. doi: 10.1634/theoncologist.2011-0427 Dequen P Lorigan P Jansen JP van Baardewijk M Ouwens MJ Kotapati S Systematic review and network meta-analysis of overall survival comparing 3 mg/kg ipilimumab with alternative therapies in the management of pretreated patients with unresectable stage III or IV melanoma Oncologist 2012 17 1376 85 10.1634/theoncologist.2011-0427Open DOISearch in Google Scholar

10Rulli E, Legramandi L, Salvati L, Mandala M. The impact of targeted therapies and immunotherapy in melanoma brain metastases: a systematic review and meta-analysis. Cancer 2019; 125: 3776-89. doi: 10.1002/cncr.32375 Rulli E Legramandi L Salvati L Mandala M The impact of targeted therapies and immunotherapy in melanoma brain metastases: a systematic review and meta-analysis Cancer 2019 125 3776 89 10.1002/cncr.32375Open DOISearch in Google Scholar

11van Opijnen MP, Dirven L, Coremans IEM, Taphoorn MJB, Kapiteijn EHW. The impact of current treatment modalities on the outcomes of patients with melanoma brain metastases: a systematic review. Int J Cancer 2020; 146: 1479-89. doi: 10.1002/ijc.32696 van Opijnen MP Dirven L Coremans IEM Taphoorn MJB Kapiteijn EHW The impact of current treatment modalities on the outcomes of patients with melanoma brain metastases: a systematic review Int J Cancer 2020 146 1479 89 10.1002/ijc.32696Open DOISearch in Google Scholar

12Coit DG, Thompson JA, Albertini MR, Barker C, Carson III WE, Contreras C, et al. Cutaneous melanoma, version 2.2019, NCCN clinical practice guidelines in oncology. Natl Compr Canc Netw 2019; 17: e1. doi: 10.6004/jnccn.2019.0018 Coit DG Thompson JA Albertini MR Barker C Carson III WE Contreras C et al Cutaneous melanoma, version 2.2019, NCCN clinical practice guidelines in oncology Natl Compr Canc Netw 2019 17 e1 10.6004/jnccn.2019.001830959471Open DOISearch in Google Scholar

13Long GS, Shivalingam B, Carlino M, Hong, A, Atkinson, V, Kefford, R, et al. Summary of recommendations and practice points: treatment approaches to brain metastases for patients with melanoma. Sydney: Cancer Council Australia; 2019 [updated 2019 Mar 7]; [cited 2021 Jan 28]. Available at: https://wiki.cancer.org.au/australia/Guidelines:Melanoma/Summary_of_treatment_approaches_to_brain_metastases Long GS Shivalingam B Carlino M Hong A Atkinson V Kefford R et al Summary of recommendations and practice points: treatment approaches to brain metastases for patients with melanoma Sydney Cancer Council Australia 2019 [updated 2019 Mar 7]; [cited 2021 Jan 28]. Available at https://wiki.cancer.org.au/australia/Guidelines:Melanoma/Summary_of_treatment_approaches_to_brain_metastasesSearch in Google Scholar

14Michielin O, Van Akkooi A, Ascierto P, Dummer R, Keilholz U. Cutaneous melanoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 2019; 30: 1884-901. doi: 10.1093/annonc/mdz411 Michielin O Van Akkooi A Ascierto P Dummer R Keilholz U Cutaneous melanoma: ESMO clinical practice guidelines for diagnosis, treatment and follow-up Ann Oncol 2019 30 1884 901 10.1093/annonc/mdz41131566661Open DOISearch in Google Scholar

15Hong AM, Waldstein C, Shivalingam B, Carlino MS, Atkinson V, Kefford RF, et al. Management of melanoma brain metastases: evidence-based clinical practice guidelines by Cancer Council Australia. Eur J Cancer 2021; 142: 10-7. doi: 10.1016/j.ejca.2020.10.013 Hong AM Waldstein C Shivalingam B Carlino MS Atkinson V Kefford RF et al Management of melanoma brain metastases: evidence-based clinical practice guidelines by Cancer Council Australia Eur J Cancer 2021 142 10 7 10.1016/j.ejca.2020.10.01333207293Open DOISearch in Google Scholar

16Tsao MN, Lloyd NS, Wong RK, Rakovitch E, Chow E, Laperriere N. Radiotherapeutic management of brain metastases: a systematic review and meta-analysis. Cancer Treat Rev 2005; 31: 256-73. doi: 10.1016/j.ctrv.2005.04.007 Tsao MN Lloyd NS Wong RK Rakovitch E Chow E Laperriere N Radiotherapeutic management of brain metastases: a systematic review and meta-analysis Cancer Treat Rev 2005 31 256 73 10.1016/j.ctrv.2005.04.00715951117Open DOISearch in Google Scholar

17Andrews DW, Scott CB, Sperduto PW, Flanders AE, Gaspar LE, Schell MC, et al. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet 2004; 363: 1665-72. doi: 10.1016/S0140-6736(04)16250-8 Andrews DW Scott CB Sperduto PW Flanders AE Gaspar LE Schell MC et al Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial Lancet 2004 363 1665 72 10.1016/S0140-6736(04)16250-815158627Open DOISearch in Google Scholar

18Chen JC, Petrovich Z, O’Day S, Morton D, Essner R, Giannotta SL, et al. Stereotactic radiosurgery in the treatment of metastatic disease to the brain. Neurosurgery 2000; 47: 268-81. doi: 10.1097/00006123-200008000-00003 Chen JC Petrovich Z O’Day S Morton D Essner R Giannotta SL et al Stereotactic radiosurgery in the treatment of metastatic disease to the brain Neurosurgery 2000 47 268 81 10.1097/00006123-200008000-0000310942000Open DOISearch in Google Scholar

19Brastianos HC, Nguyen P, Sahgal A, Eisenhauer EA, Baetz T, Hanna TP. Association of innovations in radiotherapy and systemic treatments with clinical outcomes in patients with melanoma brain metastasis from 2007 to 2016. JAMA Netw Open 2020; 3: e208204. doi: 10.1001/jamanetworko-pen.2020.8204 Brastianos HC Nguyen P Sahgal A Eisenhauer EA Baetz T Hanna TP Association of innovations in radiotherapy and systemic treatments with clinical outcomes in patients with melanoma brain metastasis from 2007 to 2016 JAMA Netw Open 2020 3 e208204 10.1001/jamanetworko-pen.2020.8204Open DOISearch in Google Scholar

20Barbour AB, Jacobs CD, Williamson H, Floyd SR, Suneja G, Torok JA, et al. Radiation therapy practice patterns for brain metastases in the United States in the stereotactic radiosurgery era. Adv Radiat Oncol 2020; 5: 43-52. doi: 10.1016/j.adro.2019.07.012 Barbour AB Jacobs CD Williamson H Floyd SR Suneja G Torok JA et al Radiation therapy practice patterns for brain metastases in the United States in the stereotactic radiosurgery era Adv Radiat Oncol 2020 5 43 52 10.1016/j.adro.2019.07.012700494032051889Open DOISearch in Google Scholar

21Sandler KA, Shaverdian N, Cook RR, Kishan AU, King CR, Yang I, et al. Treatment trends for patients with brain metastases: does practice reflect the data? Cancer 2017; 123: 2274-82. doi: 10.1002/cncr.30607 Sandler KA Shaverdian N Cook RR Kishan AU King CR Yang I et al Treatment trends for patients with brain metastases: does practice reflect the data? Cancer 2017 123 2274 82 10.1002/cncr.3060728178376Open DOISearch in Google Scholar

22Waldstein C, Wang W, Lo S, Shivalingam B, Fogarty GB, Carlino MS, et al. Melanoma brain metastases: the outcome of whole brain radiation therapy in the era of effective systemic therapy. Ther Radiol Oncol 2021; 5: 1-11. doi: 10.21037/tro-21-6 Waldstein C Wang W Lo S Shivalingam B Fogarty GB Carlino MS et al Melanoma brain metastases: the outcome of whole brain radiation therapy in the era of effective systemic therapy Ther Radiol Oncol 2021 5 1 11 10.21037/tro-21-6Open DOISearch in Google Scholar

23NCCN. NCCN Guidelines Version 3.2022 Melanoma: Cutaneous US2022. [cited 2022 Mar 15]. Available at: https://www.nccn.org/professionals/physician_gls/pdf/cutaneous_melanoma.pdf NCCN. NCCN Guidelines Version 3.2022 Melanoma: Cutaneous US2022. [cited 2022 Mar 15] Available at https://www.nccn.org/professionals/physician_gls/pdf/cutaneous_melanoma.pdfSearch in Google Scholar

24Garbe C, Amaral T, Peris K, Hauschild A, Arenberger P, Bastholt L, et al. European consensus-based interdisciplinary guideline for melanoma. Part 2: Treatment - Update 2019. Eur J Cancer 2020; 126: 159-77. doi: 10.1016/j.ejca.2019.11.015 Garbe C Amaral T Peris K Hauschild A Arenberger P Bastholt L et al European consensus-based interdisciplinary guideline for melanoma Part 2: Treatment - Update 2019. Eur J Cancer 2020 126 159 77 10.1016/j.ejca.2019.11.01531866016Open DOISearch in Google Scholar

25Peterson J, Welch V, Losos M, Tugwell P. The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa: Ottawa Hospital Research Institute. 2011. [cited 2022 Mar 14]. Available at: http://www.ohri.ca/programs/clinical_epidemiology/oxford.htm Peterson J Welch V Losos M Tugwell P The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses Ottawa Ottawa Hospital Research Institute 2011 [cited 2022 Mar 14]. Available at http://www.ohri.ca/programs/clinical_epidemiology/oxford.htmSearch in Google Scholar

26Higgins JP, Altman DG, Gøtzsche PC, Jüni P, Moher D, Oxman AD, et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomsied trials. BMJ 2011; 343: d5928. doi: 10.1136/bmj.d5928 Higgins JP Altman DG Gøtzsche PC Jüni P Moher D Oxman AD et al The Cochrane Collaboration’s tool for assessing risk of bias in randomsied trials BMJ 2011 343 d5928 10.1136/bmj.d5928319624522008217Open DOISearch in Google Scholar

27IBM. Statistical Software for the Social Sciences (SPSS) version 25. Armonk, NY: IBM Corp; 2016. IBM. Statistical Software for the Social Sciences (SPSS) version 25 Armonk, NY IBM Corp 2016Search in Google Scholar

28Hauswald H, Bernhardt D, Krug D, Katayama S, Habl G, Lorenzo Bermejo J, et al. Whole-brain helical tomotherapy with integrated boost for brain metastases in patients with malignant melanoma - final results of the BRAIN-RT trial. Cancer Manag Res 2019; 11: 4669-76. doi: 10.2147/CMAR.S204729 Hauswald H Bernhardt D Krug D Katayama S Habl G Lorenzo Bermejo J et al Whole-brain helical tomotherapy with integrated boost for brain metastases in patients with malignant melanoma - final results of the BRAIN-RT trial Cancer Manag Res 2019 11 4669 76 10.2147/CMAR.S204729653883531213892Open DOISearch in Google Scholar

29Gupta A, Roberts C, Tysoe F, Goff M, Nobes J, Lester J, et al. RADVAN: a randomised phase 2 trial of WBRT plus vandetanib for melanoma brain metastases - results and lessons learnt. Br J Cancer 2016; 115: 1193-200. doi: 10.1038/bjc.2016.318 Gupta A Roberts C Tysoe F Goff M Nobes J Lester J et al RADVAN: a randomised phase 2 trial of WBRT plus vandetanib for melanoma brain metastases - results and lessons learnt Br J Cancer 2016 115 1193 200 10.1038/bjc.2016.318510489127711083Open DOISearch in Google Scholar

30Hong AM, Fogarty GB, Dolven-Jacobsen K, Burmeister BH, Lo SN, Haydu LE, et al. Adjuvant whole-brain radiation therapy compared with observation after local treatment of melanoma brain metastases: a multicenter, randomized phase III trial. J Clin Oncol 2019; 37: 3132-41. doi: 10.1200/JCO.19.01414 Hong AM Fogarty GB Dolven-Jacobsen K Burmeister BH Lo SN Haydu LE et al Adjuvant whole-brain radiation therapy compared with observation after local treatment of melanoma brain metastases: a multicenter, randomized phase III trial J Clin Oncol 2019 37 3132 41 10.1200/JCO.19.0141431553661Open DOISearch in Google Scholar

31Partl R, Richtig E, Avian A, Berghold A, Kapp KS. Karnofsky performance status and lactate dehydrogenase predict the benefit of palliative whole-brain irradiation in patients with advanced intra-and extracranial metastases from malignant melanoma. Int J Radiat Oncol Biol Phys 2013; 85: 662-6. doi: 10.1016/j.ijrobp.2012.06.009 Partl R Richtig E Avian A Berghold A Kapp KS Karnofsky performance status and lactate dehydrogenase predict the benefit of palliative whole-brain irradiation in patients with advanced intra-and extracranial metastases from malignant melanoma Int J Radiat Oncol Biol Phys 2013 85 662 6 10.1016/j.ijrobp.2012.06.00922901382Open DOISearch in Google Scholar

32Samlowski WE, Watson GA, Wang M, Rao G, Klimo Jr P, Boucher K, et al. Multimodality treatment of melanoma brain metastases incorporating stereotactic radiosurgery (SRS). Cancer 2007; 109: 1855-62. doi: 10.1002/cncr.22605 Samlowski WE Watson GA Wang M Rao G Klimo Jr P Boucher K et al Multimodality treatment of melanoma brain metastases incorporating stereotactic radiosurgery (SRS) Cancer 2007 109 1855 62 10.1002/cncr.2260517351953Open DOISearch in Google Scholar

33Hauswald H, Dittmar JO, Habermehl D, Rieken S, Sterzing F, Debus J, et al. Efficacy and toxicity of whole brain radiotherapy in patients with multiple cerebral metastases from malignant melanoma. Radiat Oncol 2012; 7: 130. doi: 10.1186/1748-717X-7-130 Hauswald H Dittmar JO Habermehl D Rieken S Sterzing F Debus J et al Efficacy and toxicity of whole brain radiotherapy in patients with multiple cerebral metastases from malignant melanoma Radiat Oncol 2012 7 130 10.1186/1748-717X-7-130344438522857154Open DOISearch in Google Scholar

34Davies MA, Liu P, McIntyre S, Kim KB, Papadopoulos N, Hwu WJ, et al. Prognostic factors for survival in melanoma patients with brain metastases. Cancer 2011; 117: 1687-96. doi: 10.1002/cncr.25634 Davies MA Liu P McIntyre S Kim KB Papadopoulos N Hwu WJ et al Prognostic factors for survival in melanoma patients with brain metastases Cancer 2011 117 1687 96 10.1002/cncr.2563420960525Open DOISearch in Google Scholar

35Knisely JP, Yu JB, Flanigan J, Sznol M, Kluger HM, Chiang VL. Radiosurgery for melanoma brain metastases in the ipilimumab era and the possibility of longer survival. J Neurosurg 2012; 117: 227-33. doi: 10.3171/2012.5.JNS111929 Knisely JP Yu JB Flanigan J Sznol M Kluger HM Chiang VL Radiosurgery for melanoma brain metastases in the ipilimumab era and the possibility of longer survival J Neurosurg 2012 117 227 33 10.3171/2012.5.JNS111929609893822702482Open DOISearch in Google Scholar

36Gieger M, Wu JK, Ling MN, Wazer D, Tsai JS, Engler MJ. Response of intracranial melanoma metastases to stereotactic radiosurgery. Radiat Oncol Investig 1997; 5: 72-80. doi: 10.1002/%28SICI%291520-6823%281997%295:2%3C72::AID-ROI5%3E3.0.CO;2-G Gieger M Wu JK Ling MN Wazer D Tsai JS Engler MJ Response of intracranial melanoma metastases to stereotactic radiosurgery Radiat Oncol Investig 1997 5 72 80 10.1002/%28SICI%291520-6823%281997%295:2%3C72::AID-ROI5%3E3.0.CO;2-GOpen DOISearch in Google Scholar

37Fife K, Colman M, Stevens G, Firth I, Moon D, Shannon K, et al. Determinants of outcome in melanoma patients with cerebral metastases. J Clin Oncol 2004; 22: 1293-300. doi: 10.1200/JCO.2004.08.140 Fife K Colman M Stevens G Firth I Moon D Shannon K et al Determinants of outcome in melanoma patients with cerebral metastases J Clin Oncol 2004 22 1293 300 10.1200/JCO.2004.08.140Open DOISearch in Google Scholar

38Stevens G, Firth I, Coates A. Cerebral metastases from malignant melanoma. Radiother Oncol 1992; 23: 185-91. doi: 10.1016/0167-8140(92)90329-S Stevens G Firth I Coates A Cerebral metastases from malignant melanoma Radiother Oncol 1992 23 185 91 10.1016/0167-8140(92)90329-SOpen DOISearch in Google Scholar

39Szyszka-Charewicz B. The effectiveness of brain metastases radiotherapy in patients with melanoma. Nowotwory 2016; 66: 367-74. doi: 10.5603/NJO.2016.0066 Szyszka-Charewicz B. The effectiveness of brain metastases radiotherapy in patients with melanoma Nowotwory 2016 66 367 74 10.5603/NJO.2016.0066Open DOISearch in Google Scholar

40Isokangas OP, Muhonen T, Kajanti M, Pyrhonen S. Radiation therapy of intracranial malignant melanoma. Radiother Oncol 1996; 38: 139-44. doi: 10.1016/0167-8140(95)01691-0 Isokangas OP Muhonen T Kajanti M Pyrhonen S Radiation therapy of intracranial malignant melanoma Radiother Oncol 1996 38 139 44 10.1016/0167-8140(95)01691-0Open DOISearch in Google Scholar

41Silk AW, Bassetti MF, West BT, Tsien CI, Lao CD. Ipilimumab and radiation therapy for melanoma brain metastases. Cancer Med 2013; 2: 899-906. doi: 10.1002/cam4.140 Silk AW Bassetti MF West BT Tsien CI Lao CD Ipilimumab and radiation therapy for melanoma brain metastases Cancer Med 2013 2 899 906 10.1002/cam4.140Open DOISearch in Google Scholar

42Phillips WJ, Lo B, Ong M, Smith T, Song X. Clinical outcomes in patients with melanoma brain metastases at a tertiary cancer center. J Clin Oncol 2019; 37(Suppl 15): e13586. [abstract]. doi: 10.1200/JCO.2019.37.15-suppl.e13586 Phillips WJ Lo B Ong M Smith T Song X Clinical outcomes in patients with melanoma brain metastases at a tertiary cancer center J Clin Oncol 2019 37Suppl 15 e13586 [abstract] 10.1200/JCO.2019.37.15-suppl.e13586Open DOISearch in Google Scholar

43Byrne TN, Cascino TL, Posner JB. Brain metastasis from melanoma. J Neurooncol 1983; 1: 313-7. doi: 10.1007/BF00165714 Byrne TN Cascino TL Posner JB Brain metastasis from melanoma J Neurooncol 1983 1 313 7 10.1007/BF00165714Open DOISearch in Google Scholar

44Rate WR, Solin LJ, Turrisi AT. Palliative radiotherapy for metastatic malignant melanoma: brain metastases, bone metastases, and spinal cord compression. Int J Radiat Oncol Biol Phys 1988; 15: 859-64. doi: 10.1016/0360-3016(88)90118-6 Rate WR Solin LJ Turrisi AT Palliative radiotherapy for metastatic malignant melanoma: brain metastases, bone metastases, and spinal cord compression Int J Radiat Oncol Biol Phys 1988 15 859 64 10.1016/0360-3016(88)90118-6Open DOISearch in Google Scholar

45Cooney RM WB, Altman DG, Abreu MT, Travis SPL. Outcome measurement in clinical trials for ulcerative colitis: toward standardisation. Trials 2007; 8: 17. doi: 10.1186/1745-6215-8-17 Cooney RM WB Altman DG Abreu MT Travis SPL Outcome measurement in clinical trials for ulcerative colitis: toward standardisation Trials 2007 8 17 10.1186/1745-6215-8-17Open DOISearch in Google Scholar

46Mak KS, Van Bommel AC, Stowell C, Abrahm JL, Baker M, Baldotto CS, et al. Defining a standard set of patient-centred outcomes for lung cancer. Eur Respir J 2016; 48: 852-60. doi: 10.1183/13993003.02049-2015 Mak KS Van Bommel AC Stowell C Abrahm JL Baker M Baldotto CS et al Defining a standard set of patient-centred outcomes for lung cancer Eur Respir J 2016 48 852 60 10.1183/13993003.02049-2015500722127390281Open DOISearch in Google Scholar

47Tugwell P, Boers M, Brooks P, Simon LS, Strand V, Idzerda L. OMERACT: an international initiative to improve outcome measurement in rheumatology. Trials 2007; 8: 38. doi: 10.1186/1745-6215-8-38 Tugwell P Boers M Brooks P Simon LS Strand V Idzerda L OMERACT: an international initiative to improve outcome measurement in rheumatology Trials 2007 8 38 10.1186/1745-6215-8-38216926018039364Open DOISearch in Google Scholar

48Tong A, Manns B, Wang AYM, Hemmelgarn B, Wheeler DC, Gill J, et al. Implementing core outcomes in kidney disease: report of the Standardized Outcomes in Nephrology (SONG) implementation workshop. Kidney Int 2018; 94: 1053-68. doi: 10.1016/j.kint.2018.08.018 Tong A Manns B Wang AYM Hemmelgarn B Wheeler DC Gill J et al Implementing core outcomes in kidney disease: report of the Standardized Outcomes in Nephrology (SONG) implementation workshop Kidney Int 2018 94 1053 68 10.1016/j.kint.2018.08.018662075530360959Open DOISearch in Google Scholar

49Tunis SR, Maxwell LJ, Graham ID, Shea BJ, Beaton DE, Bingham CO, et al. Engaging stakeholders and promoting uptake of OMERACT core outcome instrument sets. J Rheumatol 2017; 44: 1551-9. doi: 10.3899/jrheum.161273 Tunis SR Maxwell LJ Graham ID Shea BJ Beaton DE Bingham CO et al Engaging stakeholders and promoting uptake of OMERACT core outcome instrument sets J Rheumatol 2017 44 1551 9 10.3899/jrheum.16127328765256Open DOISearch in Google Scholar

50Carella RJ, Gelber R, Hendrickson F, Berry HC, Cooper JS. Value of radiation therapy in the management of patients with cerebral metastases from malignant melanoma: radiation therapy oncology group brain metastases study I and II. Cancer 1980; 45: 679-83. doi: 10.1002/1097-0142(19800215)45:4<679::AID-CNCR2820450410>3.0.CO;2-J Carella RJ Gelber R Hendrickson F Berry HC Cooper JS Value of radiation therapy in the management of patients with cerebral metastases from malignant melanoma: radiation therapy oncology group brain metastases study I and II Cancer 1980 45 679 83 10.1002/1097-0142(19800215)45:4<679::AID-CNCR2820450410>3.0.CO;2-JOpen DOISearch in Google Scholar

51Katz HR. The relative effectiveness of radiation therapy, corticosteroids, and surgery in the management of melanoma metastatic to the central nervous system. Int J Radiat Oncol Biol Phys 1981; 7: 897-906. doi: 10.1016/0360-3016(81)90006-7 Katz HR The relative effectiveness of radiation therapy, corticosteroids, and surgery in the management of melanoma metastatic to the central nervous system Int J Radiat Oncol Biol Phys 1981 7 897 906 10.1016/0360-3016(81)90006-7Open DOISearch in Google Scholar

52Vlock DR, Kirkwood JM, Leutzinger C, Kapp DS, Fischer JJ. High-dose fraction radiation therapy for intracranial metastases of malignant melanoma: a comparison with low-dose fraction therapy. Cancer 1982; 49: 2289-94. doi: 10.1002/1097-0142(19820601)49:11<2289::AID-CNCR2820491115>3.0.CO;2-8 Vlock DR Kirkwood JM Leutzinger C Kapp DS Fischer JJ High-dose fraction radiation therapy for intracranial metastases of malignant melanoma: a comparison with low-dose fraction therapy Cancer 1982 49 2289 94 10.1002/1097-0142(19820601)49:11<2289::AID-CNCR2820491115>3.0.CO;2-8Open DOISearch in Google Scholar

53Stridsklev IC, Hagen S, Klepp O. Radiation therapy for brain metastases from malignant melanoma. Acta Radiol Oncol 1984; 23: 231-5. doi: 10.3109/02841868409136017 Stridsklev IC Hagen S Klepp O Radiation therapy for brain metastases from malignant melanoma Acta Radiol Oncol 1984 23 231 5 10.3109/02841868409136017Open DOISearch in Google Scholar

54Choi KN, Withers HR, Rotman M. Metastatic melanoma in brain. Rapid treatment or large dose fractions. Cancer 1985; 56: 10-5. doi: 10.1002/1097-0142(19850701)56:1<10::AID-CNCR2820560103>3.0.CO;2-G Choi KN Withers HR Rotman M Metastatic melanoma in brain Rapid treatment or large dose fractions. Cancer 1985 56 10 5 10.1002/1097-0142(19850701)56:1<10::AID-CNCR2820560103>3.0.CO;2-GOpen DOISearch in Google Scholar

55Choi KN, Withers HR, Rotman M. Intracranial metastases from melanoma. Clinical features and treatment by accelerated fractionation. Cancer 1985; 56: 1-9. doi: 10.1002/1097-0142%2819850701%2956:1%3C1::AID-CNCR2820560102%3E3.0.CO;2-X Choi KN Withers HR Rotman M Intracranial metastases from melanoma Clinical features and treatment by accelerated fractionation. Cancer 1985 56 1 9 10.1002/1097-0142%2819850701%2956:1%3C1::AID-CNCR2820560102%3E3.0.CO;2-XOpen DOISearch in Google Scholar

56Ziegler JC, Cooper JS. Brain metastases from malignant melanoma: conventional vs. high-dose-per-fraction radiotherapy. Int J Radiat Oncol Biol Phys 1986; 12: 1839-42. doi: 10.1016/0360-3016(86)90327-5 Ziegler JC Cooper JS Brain metastases from malignant melanoma: conventional vs high-dose-per-fraction radiotherapy. Int J Radiat Oncol Biol Phys 1986 12 1839 42 10.1016/0360-3016(86)90327-53759534Open DOISearch in Google Scholar

57Hagen NA, Cirrincione C, Thaler HT, DeAngelis LM. The role of radiation therapy following resection of single brain metastasis from melanoma. Neurology 1990; 40: 158-60. doi: 10.1212/WNL.40.1.158 Hagen NA Cirrincione C Thaler HT DeAngelis LM The role of radiation therapy following resection of single brain metastasis from melanoma Neurology 1990 40 158 60 10.1212/WNL.40.1.158Open DOISearch in Google Scholar

58Somaza S, Kondziolka D, Lunsford LD, Kirkwood JM, Flickinger JC. Stereotactic radiosurgery for cerebral metastatic melanoma. J Neurosurg 1993; 79: 661-6. doi: 10.3171/jns.1993.79.5.0661 Somaza S Kondziolka D Lunsford LD Kirkwood JM Flickinger JC Stereotactic radiosurgery for cerebral metastatic melanoma J Neurosurg 1993 79 661 6 10.3171/jns.1993.79.5.06618410244Open DOISearch in Google Scholar

59Willner J, Bohndorf W. [CNS metastases in malignant melanomas]. [German]. Strahlenther Onkol 1995; 171: 165-73. PMID: 7709333 Willner J Bohndorf W [CNS metastases in malignant melanomas] [German]. Strahlenther Onkol 1995 171 165 73 PMID: 7709333Search in Google Scholar

60Skibber JM, Soong SJ, Austin L, Balch CM, Sawaya RE. Cranial irradiation after surgical excision of brain metastases in melanoma patients. Ann Surg Oncol 1996; 3: 118-23. doi: 10.1007/BF02305789 Skibber JM Soong SJ Austin L Balch CM Sawaya RE Cranial irradiation after surgical excision of brain metastases in melanoma patients Ann Surg Oncol 1996 3 118 23 10.1007/BF023057898646510Open DOISearch in Google Scholar

61Gupta G, Robertson AG, MacKie RM. Cerebral metastases of cutaneous melanoma. Br J Cancer 1997; 76: 256-9. doi: 10.1038/bjc.1997.371 Gupta G Robertson AG MacKie RM Cerebral metastases of cutaneous melanoma Br J Cancer 1997 76 256 9 10.1038/bjc.1997.37122239309231928Open DOISearch in Google Scholar

62Grob JJ, Regis J, Laurans R, Delaunay M, Wolkenstein P, Paul K, et al. Radiosurgery without whole brain radiotherapy in melanoma brain metastases. Eur J Cancer 1998; 34: 1187-92. doi: 10.1016/S0959-8049%2898%2900026-4 Grob JJ Regis J Laurans R Delaunay M Wolkenstein P Paul K et al Radiosurgery without whole brain radiotherapy in melanoma brain metastases Eur J Cancer 1998 34 1187 92 10.1016/S0959-8049%2898%2900026-4Open DOISearch in Google Scholar

63Sampson JH, Carter JH, Friedman AH, Seigler HF. Demographics, prognosis, and therapy in 702 patients with brain metastases from malignant melanoma. J Neurosurg 1998; 88: 11-20. doi: 10.3171/jns.1998.88.1.0011 Sampson JH Carter JH Friedman AH Seigler HF Demographics, prognosis, and therapy in 702 patients with brain metastases from malignant melanoma J Neurosurg 1998 88 11 20 10.3171/jns.1998.88.1.00119420067Open DOISearch in Google Scholar

64Seung SK, Sneed PK, McDermott MW, Shu HK, Leong SP, Chang S, et al. Gamma knife radiosurgery for malignant melanoma brain metastases. Cancer J Sci Am 1998; 4: 103-9. PMID: 9532412 Seung SK Sneed PK McDermott MW Shu HK Leong SP Chang S et al Gamma knife radiosurgery for malignant melanoma brain metastases Cancer J Sci Am 1998 4 103 9 PMID: 9532412Search in Google Scholar

65Lavine SD, Petrovich Z, Cohen-Gadol AA, Masri LS, Morton DL, O’Day SJ, et al. Gamma knife radiosurgery for metastatic melanoma: an analysis of survival, outcome, and complications. Neurosurgery 1999; 44: 59-66. doi: 10.1097/00006123-199901000-00031 Lavine SD Petrovich Z Cohen-Gadol AA Masri LS Morton DL O’Day SJ et al Gamma knife radiosurgery for metastatic melanoma: an analysis of survival, outcome, and complications Neurosurgery 1999 44 59 66 10.1097/00006123-199901000-000319894964Open DOISearch in Google Scholar

66Konstadoulakis M, Messaris E, Zografos G, Androulakis G. Prognostic factors in malignant melanoma patients with solitary or multiple brain metastases: is there a role for surgery? J Neurosurg Sci 2000; 44: 211-8. PMID: 11327290 Konstadoulakis M Messaris E Zografos G Androulakis G Prognostic factors in malignant melanoma patients with solitary or multiple brain metastases: is there a role for surgery? J Neurosurg Sci 2000 44 211 8 PMID: 11327290Search in Google Scholar

67Ellerhorst J, Strom E, Nardone E, McCutcheon I. Whole brain irradiation for patients with metastatic melanoma: a review of 87 cases. Int J Radiat Oncol Biol Phys 2001; 49: 93-7. doi: 10.1016/S0360-3016(00)01355-9 Ellerhorst J Strom E Nardone E McCutcheon I Whole brain irradiation for patients with metastatic melanoma: a review of 87 cases Int J Radiat Oncol Biol Phys 2001 49 93 7 10.1016/S0360-3016(00)01355-911163501Open DOISearch in Google Scholar

68Buchsbaum JC, Suh JH, Lee SY, Chidel MA, Greskovich JF, Barnett GH. Survival by radiation therapy oncology group recursive partitioning analysis class and treatment modality in patients with brain metastases from malignant melanoma: a retrospective study. Cancer 2002; 94: 2265-72. doi: 10.1002/cncr.10426 Buchsbaum JC Suh JH Lee SY Chidel MA Greskovich JF Barnett GH Survival by radiation therapy oncology group recursive partitioning analysis class and treatment modality in patients with brain metastases from malignant melanoma: a retrospective study Cancer 2002 94 2265 72 10.1002/cncr.1042612001126Open DOISearch in Google Scholar

69Gonzalez-Martinez J, Hernandez L, Zamorano L, Sloan A, Levin K, Lo S, et al. Gamma knife radiosurgery for intracranial metastatic melanoma: a 6-year experience. J Neurosurg 2002; 97(Suppl. 5): 494-8. doi: 10.3171/jns.2002.97.supplement_5.0494 Gonzalez-Martinez J Hernandez L Zamorano L Sloan A Levin K Lo S et al Gamma knife radiosurgery for intracranial metastatic melanoma: a 6-year experience J Neurosurg 2002 97Suppl. 5 494 8 10.3171/jns.2002.97.supplement_5.0494Open DOISearch in Google Scholar

70Mingione V, Oliveira M, Prasad D, Steiner M, Steiner L. Gamma surgery for melanoma metastases in the brain. J Neurosurg 2002; 96: 544-51. doi: 10.3171/jns.2002.96.3.0544 Mingione V Oliveira M Prasad D Steiner M Steiner L Gamma surgery for melanoma metastases in the brain J Neurosurg 2002 96 544 51 10.3171/jns.2002.96.3.054411883840Open DOISearch in Google Scholar

71Noel G, Simon JM, Valery CA, Cornu P, Boisserie G, Ledu D, et al. Linac radiosurgery for brain metastasis of melanoma. Stereotact Funct Neurosurg 2002; 79: 245-55. doi: 10.1159/000070838 Noel G Simon JM Valery CA Cornu P Boisserie G Ledu D et al Linac radiosurgery for brain metastasis of melanoma Stereotact Funct Neurosurg 2002 79 245 55 10.1159/00007083812890983Open DOISearch in Google Scholar

72Yu C, Chen JCT, Apuzzo MLJ, O’Day S, Giannotta SL, Weber JS, et al. Metastatic melanoma to the brain: prognostic factors after gamma knife radiosurgery. Int J Radiat Oncol Biol Phys 2002; 52: 1277-87. doi: 10.1016/S0360-3016%2801%2902772-9 Yu C Chen JCT Apuzzo MLJ O’Day S Giannotta SL Weber JS et al Metastatic melanoma to the brain: prognostic factors after gamma knife radiosurgery Int J Radiat Oncol Biol Phys 2002 52 1277 87 10.1016/S0360-3016%2801%2902772-9Open DOISearch in Google Scholar

73Zacest AC, Besser M, Stevens G, Thompson JF, McCarthy WH, Culjak G. Surgical management of cerebral metastases from melanoma: outcome in 147 patients treated at a single institution over two decades. J Neurosurg 2002; 96: 552-8. doi: 10.3171/jns.2002.96.3.0552 Zacest AC Besser M Stevens G Thompson JF McCarthy WH Culjak G Surgical management of cerebral metastases from melanoma: outcome in 147 patients treated at a single institution over two decades J Neurosurg 2002 96 552 8 10.3171/jns.2002.96.3.055211883841Open DOISearch in Google Scholar

74Harrison BE, Johnson JL, Clough RW, Halperin EC. Selection of patients with melanoma brain metastases for aggressive treatment. Am J Clin Oncol 2003; 26: 354-7. doi: 10.1097/00000421-200308000-00009 Harrison BE Johnson JL Clough RW Halperin EC Selection of patients with melanoma brain metastases for aggressive treatment Am J Clin Oncol 2003 26 354 7 10.1097/00000421-200308000-00009Open DOISearch in Google Scholar

75Conill C, Fernandez-Ibiza J, Malvehy J, Puig S, Sanchez M, Castel T. Temozolomide in patients with melanoma brain metastases treated with whole brain irradiation. Med Clin (Barc) 2004; 122: 413-5. doi: 10.1016/s0025-7753(04)74256-6 Conill C Fernandez-Ibiza J Malvehy J Puig S Sanchez M Castel T Temozolomide in patients with melanoma brain metastases treated with whole brain irradiation Med Clin (Barc) 2004 122 413 5 10.1016/s0025-7753(04)74256-615066248Open DOISearch in Google Scholar

76Meier S, Baumert BG, Maier T, Wellis G, Burg G, Seifert B, et al. Survival and prognostic factors in patients with brain metastases from malignant melanoma. Onkologie 2004; 27: 145-9. doi: 10.1159/000076903 Meier S Baumert BG Maier T Wellis G Burg G Seifert B et al Survival and prognostic factors in patients with brain metastases from malignant melanoma Onkologie 2004 27 145 9 10.1159/00007690315138346Open DOISearch in Google Scholar

77Morris SL, Low SH, A’Hern RP, Eisen TG, Gore ME, Nutting CM, et al. A prognostic index that predicts outcome following palliative whole brain radiotherapy for patients with metastatic malignant melanoma. Br J Cancer 2004; 91: 829-33. doi: 10.1038/sj.bjc.6602018 Morris SL Low SH A’Hern RP Eisen TG Gore ME Nutting CM et al A prognostic index that predicts outcome following palliative whole brain radiotherapy for patients with metastatic malignant melanoma Br J Cancer 2004 91 829 33 10.1038/sj.bjc.6602018240988115305201Open DOISearch in Google Scholar

78Radbill AE, Fiveash JF, Falkenberg ET, Guthrie BL, Young PE, Meleth S, et al. Initial treatment of melanoma brain metastases using gamma knife radiosurgery: an evaluation of efficacy and toxicity. Cancer 2004; 101: 825-33. doi: 10.1002/cncr.20447 Radbill AE Fiveash JF Falkenberg ET Guthrie BL Young PE Meleth S et al Initial treatment of melanoma brain metastases using gamma knife radiosurgery: an evaluation of efficacy and toxicity Cancer 2004 101 825 33 10.1002/cncr.2044715305416Open DOISearch in Google Scholar

79Selek U, Chang EL, Hassenbusch SJ, 3rd, Shiu AS, Lang FF, Allen P, et al. Stereotactic radiosurgical treatment in 103 patients for 153 cerebral melanoma metastases. Int J Radiat Oncol Biol Phys 2004; 59: 1097-106. doi: 10.1016/j.ijrobp.2003.12.037 Selek U Chang EL Hassenbusch SJ 3rd Shiu AS Lang FF Allen P et al Stereotactic radiosurgical treatment in 103 patients for 153 cerebral melanoma metastases Int J Radiat Oncol Biol Phys 2004 59 1097 106 10.1016/j.ijrobp.2003.12.03715234044Open DOISearch in Google Scholar

80Stone A, Cooper J, Koenig KL, Golfinos JG, Oratz R. A comparison of survival rates for treatment of melanoma metastatic to the brain. Cancer Invest 2004; 22: 492-7. doi: 10.1081/CNV-200026387 Stone A Cooper J Koenig KL Golfinos JG Oratz R A comparison of survival rates for treatment of melanoma metastatic to the brain Cancer Invest 2004 22 492 7 10.1081/CNV-20002638715565805Open DOISearch in Google Scholar

81Koc M, McGregor J, Grecula J, Bauer CJ, Gupta N, Gahbauer RA. Gamma Knife radiosurgery for intracranial metastatic melanoma: an analysis of survival and prognostic factors. J Neurooncol 2005; 71: 307-13. doi: 10.1007/s11060-004-2027-1 Koc M McGregor J Grecula J Bauer CJ Gupta N Gahbauer RA Gamma Knife radiosurgery for intracranial metastatic melanoma: an analysis of survival and prognostic factors J Neurooncol 2005 71 307 13 10.1007/s11060-004-2027-115735922Open DOISearch in Google Scholar

82Panagiotou IE, Brountzos EN, Kelekis DA, Papathanasiou MA, Bafaloukos DI. Cerebral metastases of malignant melanoma: contemporary treatment modalities and survival outcome. Neoplasma 2005; 52: 150-8. PMID: 15800714 Panagiotou IE Brountzos EN Kelekis DA Papathanasiou MA Bafaloukos DI Cerebral metastases of malignant melanoma: contemporary treatment modalities and survival outcome Neoplasma 2005 52 150 8 PMID: 15800714Search in Google Scholar

83Rhomberg W, Eiter H, Boehler F, Saely C, Strohal R. Combined razoxane and radiotherapy for melanoma brain metastases. a retrospective analysis. J Neurooncol 2005; 74: 295-9. doi: 10.1007/s11060-004-7557-z Rhomberg W Eiter H Boehler F Saely C Strohal R Combined razoxane and radiotherapy for melanoma brain metastases a retrospective analysis. J Neurooncol 2005 74 295 9 10.1007/s11060-004-7557-z16086112Open DOISearch in Google Scholar

84Christopoulou A, Retsas S, Kingsley D, Paddick I, Lindquist C. Integration of gamma knife surgery in the management of cerebral metastases from melanoma. Melanoma Res 2006; 16: 51-7. doi: 10.1097/01.cmr.0000198451.26827.b2 Christopoulou A Retsas S Kingsley D Paddick I Lindquist C Integration of gamma knife surgery in the management of cerebral metastases from melanoma Melanoma Res 2006 16 51 7 10.1097/01.cmr.0000198451.26827.b216432456Open DOISearch in Google Scholar

85Gaudy-Marqueste C, Regis JM, Muracciole X, Laurans R, Richard MA, Bonerandi JJ, et al. Gamma-Knife radiosurgery in the management of melanoma patients with brain metastases: a series of 106 patients without whole-brain radiotherapy. Int J Radiat Oncol Biol Phys 2006; 65: 809-16. doi: 10.1016/j.ijrobp.2006.01.024 Gaudy-Marqueste C Regis JM Muracciole X Laurans R Richard MA Bonerandi JJ et al Gamma-Knife radiosurgery in the management of melanoma patients with brain metastases: a series of 106 patients without whole-brain radiotherapy Int J Radiat Oncol Biol Phys 2006 65 809 16 10.1016/j.ijrobp.2006.01.02416682138Open DOISearch in Google Scholar

86Conill C, Berenguer J, Vargas M, Lopez-Soriano A, Valduvieco I, Marruecos J, et al. Incidence of radiation-induced leukoencephalopathy after whole brain radiotherapy in patients with brain metastases. Clin Transl Oncol 2007; 9: 590-5. doi: 10.1007/s12094-007-0108-2 Conill C Berenguer J Vargas M Lopez-Soriano A Valduvieco I Marruecos J et al Incidence of radiation-induced leukoencephalopathy after whole brain radiotherapy in patients with brain metastases Clin Transl Oncol 2007 9 590 5 10.1007/s12094-007-0108-217921107Open DOISearch in Google Scholar

87Mathieu D, Kondziolka D, Cooper PB, Flickinger JC, Niranjan A, Agarwala S, et al. Gamma knife radiosurgery in the management of malignant melanoma brain metastases. Neurosurgery 2007; 60: 471-81. doi: 10.1227/01.NEU.0000255342.10780.52 Mathieu D Kondziolka D Cooper PB Flickinger JC Niranjan A Agarwala S et al Gamma knife radiosurgery in the management of malignant melanoma brain metastases Neurosurgery 2007 60 471 81 10.1227/01.NEU.0000255342.10780.5217327791Open DOISearch in Google Scholar

88Redmond AJ, Diluna ML, Hebert R, Moliterno JA, Desai R, Knisely JP, et al. Gamma Knife surgery for the treatment of melanoma metastases: the effect of intratumoral hemorrhage on survival. J Neurosurg 2008; 109 (Suppl): 99-105. doi: 10.3171/JNS/2008/109/12/S16 Redmond AJ Diluna ML Hebert R Moliterno JA Desai R Knisely JP et al Gamma Knife surgery for the treatment of melanoma metastases: the effect of intratumoral hemorrhage on survival J Neurosurg 2008 109 Suppl 99 105 10.3171/JNS/2008/109/12/S1619123895Open DOISearch in Google Scholar

89Carrubba CJ, Vitaz TW. Factors affecting the outcome after treatment for metastatic melanoma to the brain. Surg Neurol 2009; 72: 707-11. doi: 10.1016/j.surneu.2009.03.005 Carrubba CJ Vitaz TW Factors affecting the outcome after treatment for metastatic melanoma to the brain Surg Neurol 2009 72 707 11 10.1016/j.surneu.2009.03.00519604550Open DOISearch in Google Scholar

90Ahmad S, Ricco A, Brown R, Hanlon A, Yang J, Feng J, et al. Single institutional experience of stereotactic radiosurgery alone for first brain metastatic event and salvage of second brain metastatic event in a community setting with review of the literature. Front Oncol 2017; 7: 32. doi: 10.3389/fonc.2017.00032 Ahmad S Ricco A Brown R Hanlon A Yang J Feng J et al Single institutional experience of stereotactic radiosurgery alone for first brain metastatic event and salvage of second brain metastatic event in a community setting with review of the literature Front Oncol 2017 7 32 10.3389/fonc.2017.00032534302128337424Open DOISearch in Google Scholar

91Rades D, Heisterkamp C, Huttenlocher S, Bohlen G, Dunst J, Haatanen T, et al. Dose escalation of whole-brain radiotherapy for brain metastases from melanoma. Int J Radiat Oncol Biol Phys 2010; 77: 537-41. doi: 10.1016/j.ijrobp.2009.05.001 Rades D Heisterkamp C Huttenlocher S Bohlen G Dunst J Haatanen T et al Dose escalation of whole-brain radiotherapy for brain metastases from melanoma Int J Radiat Oncol Biol Phys 2010 77 537 41 10.1016/j.ijrobp.2009.05.00119733017Open DOISearch in Google Scholar

92Schild SE, Behl D, Markovic SN, Brown PD, Sande JR, Deming RL, et al. Brain metastases from melanoma: is there a role for concurrent temozolomide in addition to whole brain radiation therapy? Am J Clin Oncol 2010; 33: 633-6. doi: 10.1097/COC.0b013e3181c4c54b Schild SE Behl D Markovic SN Brown PD Sande JR Deming RL et al Brain metastases from melanoma: is there a role for concurrent temozolomide in addition to whole brain radiation therapy? Am J Clin Oncol 2010 33 633 6 10.1097/COC.0b013e3181c4c54b569055520042969Open DOISearch in Google Scholar

93Staudt M, Lasithiotakis K, Leiter U, Meier F, Eigentler T, Bamberg M, et al. Determinants of survival in patients with brain metastases from cutaneous melanoma. Br J Cancer 2010; 102: 1213-8. doi: 10.1038/sj.bjc.6605622 Staudt M Lasithiotakis K Leiter U Meier F Eigentler T Bamberg M et al Determinants of survival in patients with brain metastases from cutaneous melanoma Br J Cancer 2010 102 1213 8 10.1038/sj.bjc.6605622285600220372154Open DOISearch in Google Scholar

94Eigentler TK, Figl A, Krex D, Mohr P, Mauch C, Rass K, et al. Number of metastases, serum lactate dehydrogenase level, and type of treatment are prognostic factors in patients with brain metastases of malignant melanoma. Cancer 2011; 117: 1697-703. doi: 10.1002/cncr.25631 Eigentler TK Figl A Krex D Mohr P Mauch C Rass K et al Number of metastases, serum lactate dehydrogenase level, and type of treatment are prognostic factors in patients with brain metastases of malignant melanoma Cancer 2011 117 1697 703 10.1002/cncr.2563121472716Open DOISearch in Google Scholar

95Liew DN, Kano H, Kondziolka D, Mathieu D, Niranjan A, Flickinger JC, et al. Outcome predictors of gamma knife surgery for melanoma brain metastases. Clinical article. J Neurosurg 2011; 114: 769-79. doi: 10.3171/2010.5.JNS1014 Liew DN Kano H Kondziolka D Mathieu D Niranjan A Flickinger JC et al Outcome predictors of gamma knife surgery for melanoma brain metastases Clinical article. J Neurosurg 2011 114 769 79 10.3171/2010.5.JNS101420524829Open DOISearch in Google Scholar

96Skeie BS, Skeie GO, Enger PO, Ganz JC, Heggdal JI, Ystevik B, et al. Gamma knife surgery in brain melanomas: absence of extracranial metastases and tumor volume strongest indicators of prolonged survival. World Neurosurg 2011; 75: 684-91; discussion 598-603. doi: 10.1016/j.wneu.2010.12.054 Skeie BS Skeie GO Enger PO Ganz JC Heggdal JI Ystevik B et al Gamma knife surgery in brain melanomas: absence of extracranial metastases and tumor volume strongest indicators of prolonged survival World Neurosurg 2011 75 684 91 discussion 598-603 10.1016/j.wneu.2010.12.05421704936Open DOISearch in Google Scholar

97Zakrzewski J, Geraghty LN, Rose AE, Christos PJ, Mazumdar M, Polsky D, et al. Clinical variables and primary tumor characteristics predictive of the development of melanoma brain metastases and post-brain metastases survival. Cancer 2011; 117: 1711-20. doi: 10.1002/cncr.25643 Zakrzewski J Geraghty LN Rose AE Christos PJ Mazumdar M Polsky D et al Clinical variables and primary tumor characteristics predictive of the development of melanoma brain metastases and post-brain metastases survival Cancer 2011 117 1711 20 10.1002/cncr.25643311702521472718Open DOISearch in Google Scholar

98Bernard ME, Wegner RE, Reineman K, Heron DE, Kirkwood J, Burton SA, et al. Linear accelerator based stereotactic radiosurgery for melanoma brain metastases. J Cancer Res Ther 2012; 8: 215-21. doi: 10.4103/0973-1482.98973 Bernard ME Wegner RE Reineman K Heron DE Kirkwood J Burton SA et al Linear accelerator based stereotactic radiosurgery for melanoma brain metastases J Cancer Res Ther 2012 8 215 21 10.4103/0973-1482.9897322842364Open DOISearch in Google Scholar

99Koay EJ, Bucheit AD, Jakob JA, Hyun ED, Settle SH, Brown PD, et al. Correlation of BRAF and NRAS mutation status with tumor characteristics and treatment outcomes in melanoma patients with brain metastasis. [abstract]. J Clin Oncol 2012; 30 (15 Suppl 1). doi: 10.1200/jco.2012.30.15_suppl.8584 Koay EJ Bucheit AD Jakob JA Hyun ED Settle SH Brown PD et al Correlation of BRAF and NRAS mutation status with tumor characteristics and treatment outcomes in melanoma patients with brain metastasis. [abstract] J Clin Oncol 2012 30 (15 Suppl 1) 10.1200/jco.2012.30.15_suppl.8584Open DOISearch in Google Scholar

100Lo SS, Radawski JD, Nelson A, Clarke JW, McGregor JM, Mayr NA, et al. Stereotactic radiosurgery with or without whole brain radiotherapy for patients with one to three melanoma brain metastases. J Radiat Oncol 2012; 1: 73-9. doi: 10.1007/s13566-012-0006-2 Lo SS Radawski JD Nelson A Clarke JW McGregor JM Mayr NA et al Stereotactic radiosurgery with or without whole brain radiotherapy for patients with one to three melanoma brain metastases J Radiat Oncol 2012 1 73 9 10.1007/s13566-012-0006-2Open DOISearch in Google Scholar

101Salvati M, Frati A, D’Elia A, Pescatori L, Piccirilli M, Pietrantonio A, et al. Single brain metastases from melanoma: remarks on a series of 84 patients. Neurosurg Rev 2012; 35: 211-8. doi: 10.1007/s10143-011-0348-z Salvati M Frati A D’Elia A Pescatori L Piccirilli M Pietrantonio A et al Single brain metastases from melanoma: remarks on a series of 84 patients Neurosurg Rev 2012 35 211 8 10.1007/s10143-011-0348-z21915621Open DOISearch in Google Scholar

102Mathew M, Tam M, Ott PA, Pavlick AC, Rush SC, Donahue BR, et al. Ipilimumab in melanoma with limited brain metastases treated with stereotactic radiosurgery. Melanoma Res 2013; 23: 191-5. doi: 10.1097/CMR.0b013e32835f3d90 Mathew M Tam M Ott PA Pavlick AC Rush SC Donahue BR et al Ipilimumab in melanoma with limited brain metastases treated with stereotactic radiosurgery Melanoma Res 2013 23 191 5 10.1097/CMR.0b013e32835f3d9023462208Open DOISearch in Google Scholar

103Miller D, Zappala V, El Hindy N, Livingstone E, Schadendorf D, Sure U, et al. Intracerebral metastases of malignant melanoma and their recurrences--a clinical analysis. Clin Neurol Neurosurg 2013; 115: 1721-8. doi: 10.1016/j.clineuro.2013.03.019 Miller D Zappala V El Hindy N Livingstone E Schadendorf D Sure U et al Intracerebral metastases of malignant melanoma and their recurrences--a clinical analysis Clin Neurol Neurosurg 2013 115 1721 8 10.1016/j.clineuro.2013.03.01923643143Open DOISearch in Google Scholar

104Zukauskaite R, Schmidt H, Asmussen JT, Hansen O, Bastholt L. Asymptomatic brain metastases in patients with cutaneous metastatic malignant melanoma. Melanoma Res 2013; 23: 21-6. doi: 10.1097/CMR.0b013e32835ae915 Zukauskaite R Schmidt H Asmussen JT Hansen O Bastholt L Asymptomatic brain metastases in patients with cutaneous metastatic malignant melanoma Melanoma Res 2013 23 21 6 10.1097/CMR.0b013e32835ae91523117880Open DOISearch in Google Scholar

105Dyer MA, Arvold ND, Chen YH, Pinnell NE, Mitin T, Lee EQ, et al. The role of whole brain radiation therapy in the management of melanoma brain metastases. Radiat Oncol 2014; 9: 143. doi: 10.1186/1748-717X-9-143 Dyer MA Arvold ND Chen YH Pinnell NE Mitin T Lee EQ et al The role of whole brain radiation therapy in the management of melanoma brain metastases Radiat Oncol 2014 9 143 10.1186/1748-717X-9-143413223024954062Open DOISearch in Google Scholar

106Marcus DM, Lowe M, Khan MK, Lawson DH, Crocker IR, Shelton JW, et al. Prognostic factors for overall survival after radiosurgery for brain metastases from melanoma. Am J Clin Oncol 2014; 37: 580-4. doi: 10.1097/COC.0b013e318280d7be Marcus DM Lowe M Khan MK Lawson DH Crocker IR Shelton JW et al Prognostic factors for overall survival after radiosurgery for brain metastases from melanoma Am J Clin Oncol 2014 37 580 4 10.1097/COC.0b013e318280d7be23428955Open DOISearch in Google Scholar

107Neal MT, Chan MD, Lucas Jr JT, Loganathan A, Dillingham C, Pan E, et al. Predictors of survival, neurologic death, local failure, and distant failure after gamma knife radiosurgery for melanoma brain metastases. World Neurosurg 2014; 82: 1250-5. doi: 10.1016/j.wneu.2013.02.025 Neal MT Chan MD Lucas Jr JT Loganathan A Dillingham C Pan E et al Predictors of survival, neurologic death, local failure, and distant failure after gamma knife radiosurgery for melanoma brain metastases World Neurosurg 2014 82 1250 5 10.1016/j.wneu.2013.02.02523402867Open DOISearch in Google Scholar

108Rades D, Hornung D, Blanck O, Martens K, Khoa MT, Trang NT, et al. Stereotactic radiosurgery for newly diagnosed brain metastases: comparison of three dose levels. Strahlenther Onkol 2014; 190: 786-91. doi: 10.1007/s00066-014-0625-1 Rades D Hornung D Blanck O Martens K Khoa MT Trang NT et al Stereotactic radiosurgery for newly diagnosed brain metastases: comparison of three dose levels Strahlenther Onkol 2014 190 786 91 10.1007/s00066-014-0625-124663288Open DOISearch in Google Scholar

109Vecchio S, Spagnolo F, Merlo DF, Signori A, Acquati M, Pronzato P, et al. The treatment of melanoma brain metastases before the advent of targeted therapies: associations between therapeutic choice, clinical symptoms and outcome with survival. Melanoma Res 2014; 24: 61-7. doi: 10.1097/CMR.0000000000000029 Vecchio S Spagnolo F Merlo DF Signori A Acquati M Pronzato P et al The treatment of melanoma brain metastases before the advent of targeted therapies: associations between therapeutic choice, clinical symptoms and outcome with survival Melanoma Res 2014 24 61 7 10.1097/CMR.000000000000002924121190Open DOISearch in Google Scholar

110Christ SM, Mahadevan A, Floyd SR, Lam FC, Chen CC, Wong ET, et al. Stereotactic radiosurgery for brain metastases from malignant melanoma. Surg Neurol Int 2015; 6(Suppl 12): S355. doi: 10.4103/2152-7806.163315 Christ SM Mahadevan A Floyd SR Lam FC Chen CC Wong ET et al Stereotactic radiosurgery for brain metastases from malignant melanoma Surg Neurol Int 2015 6Suppl 12 S355 10.4103/2152-7806.163315455363626392919Open DOISearch in Google Scholar

111Frakes JM, Figura NB, Ahmed KA, Juan TH, Patel N, Latifi K, et al. Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases. J Neurosurg 2015; 123: 1261-7. doi: 10.3171/2014.12.JNS141919 Frakes JM Figura NB Ahmed KA Juan TH Patel N Latifi K et al Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases J Neurosurg 2015 123 1261 7 10.3171/2014.12.JNS14191926140482Open DOISearch in Google Scholar

112Hauswald H, Stenke A, Debus J, Combs SE. Linear accelerator-based stereotactic radiosurgery in 140 brain metastases from malignant melanoma. BMC Cancer 2015; 15: 537. doi: 10.1186/s12885-015-1517-1 Hauswald H Stenke A Debus J Combs SE Linear accelerator-based stereotactic radiosurgery in 140 brain metastases from malignant melanoma BMC Cancer 2015 15 537 10.1186/s12885-015-1517-1451144626201853Open DOISearch in Google Scholar

113Ivanov PI, Zubatkina IS, Tumarova DI, Andreev GI, Volkov NM. [Analysis of results of Gamma knife radiosurgery for patients with melanoma brain metastases]. [Russian]. Voprosy onkologii 2015; 61: 586-91. doi: УДК616.5-616-831-006;615.47.616-072.7 Ivanov PI Zubatkina IS Tumarova DI Andreev GI Volkov NM [Analysis of results of Gamma knife radiosurgery for patients with melanoma brain metastases] [Russian]. Voprosy onkologii 2015 61 586 91 УДК616.5-616-831-006;615.47.616-072.7Open DOISearch in Google Scholar

114Ly D, Bagshaw HP, Anker CJ, Tward JD, Grossmann KF, Jensen RL, et al. Local control after stereotactic radiosurgery for brain metastases in patients with melanoma with and without BRAF mutation and treatment. J Neurosurg 2015; 123: 395-401. doi: 10.3171/2014.9.JNS141425 Ly D Bagshaw HP Anker CJ Tward JD Grossmann KF Jensen RL et al Local control after stereotactic radiosurgery for brain metastases in patients with melanoma with and without BRAF mutation and treatment J Neurosurg 2015 123 395 401 10.3171/2014.9.JNS141425Open DOISearch in Google Scholar

115Ostheimer C, Bormann C, Fiedler E, Marsch W, Vordermark D. Malignant melanoma brain metastases: treatment results and prognostic factors - a single-center retrospective study. Int J Oncol 2015; 46: 2439-48. doi: 10.3892/ijo.2015.2970 Ostheimer C Bormann C Fiedler E Marsch W Vordermark D Malignant melanoma brain metastases: treatment results and prognostic factors - a single-center retrospective study Int J Oncol 2015 46 2439 48 10.3892/ijo.2015.2970Open DOISearch in Google Scholar

116Gallaher IS, Watanabe Y, DeFor TE, Dusenbery KE, Lee CK, Hunt MA, et al. BRAF mutation is associated with improved local control of melanoma brain metastases treated with Gamma knife radiosurgery. Front Oncol 2016; 6: 107. doi: 10.3389/fonc.2016.00107 Gallaher IS Watanabe Y DeFor TE Dusenbery KE Lee CK Hunt MA et al BRAF mutation is associated with improved local control of melanoma brain metastases treated with Gamma knife radiosurgery Front Oncol 2016 6 107 10.3389/fonc.2016.00107Open DOISearch in Google Scholar

117Patel BG, Ahmed KA, Johnstone PA, Yu HH, Etame AB. Initial experience with combined BRAF and MEK inhibition with stereotactic radiosurgery for BRAF mutant melanoma brain metastases. Melanoma Res 2016; 26: 382-6. doi: 10.1097/CMR.0000000000000250 Patel BG Ahmed KA Johnstone PA Yu HH Etame AB Initial experience with combined BRAF and MEK inhibition with stereotactic radiosurgery for BRAF mutant melanoma brain metastases Melanoma Res 2016 26 382 6 10.1097/CMR.0000000000000250Open DOISearch in Google Scholar

118Rades D, Sehmisch L, Bajrovic A, Janssen S, Schild SE. Comparison of 20x2 Gy and 12x3 Gy for whole-brain irradiation of multiple brain metastases from malignant melanoma. In Vivo 2016; 30: 917-9. doi: 10.21873/in-vivo.11013 Rades D Sehmisch L Bajrovic A Janssen S Schild SE Comparison of 20x2 Gy and 12x3 Gy for whole-brain irradiation of multiple brain metastases from malignant melanoma In Vivo 2016 30 917 9 10.21873/in-vivo.11013Open DOISearch in Google Scholar

119Wolf A, Zia S, Verma R, Pavlick A, Wilson M, Golfinos JG, et al. Impact on overall survival of the combination of BRAF inhibitors and stereotactic radiosurgery in patients with melanoma brain metastases. J Neurooncol 2016; 127: 607-15. doi: 10.1007/s11060-016-2072-6 Wolf A Zia S Verma R Pavlick A Wilson M Golfinos JG et al Impact on overall survival of the combination of BRAF inhibitors and stereotactic radiosurgery in patients with melanoma brain metastases J Neurooncol 2016 127 607 15 10.1007/s11060-016-2072-6Open DOISearch in Google Scholar

120Acharya S, Mahmood M, Mullen D, Yang D, Tsien CI, Huang J, et al. Distant intracranial failure in melanoma brain metastases treated with stereotactic radiosurgery in the era of immunotherapy and targeted agents. Adv Radiat Oncol 2017; 2: 572-80. doi: 10.1016/j.adro.2017.07.003 Acharya S Mahmood M Mullen D Yang D Tsien CI Huang J et al Distant intracranial failure in melanoma brain metastases treated with stereotactic radiosurgery in the era of immunotherapy and targeted agents Adv Radiat Oncol 2017 2 572 80 10.1016/j.adro.2017.07.003570741929204524Open DOISearch in Google Scholar

121All S, Patel H, Keller A, Ramakrishna NR. Initial volumetric response and local control following stereotactic radiosurgery for melanoma brain metastases. Int J Radiat Oncol Biol Phys 2017; 99 (2 Suppl 1): E62-3. doi: 10.1016/j.ijrobp.2017.06.739 All S Patel H Keller A Ramakrishna NR Initial volumetric response and local control following stereotactic radiosurgery for melanoma brain metastases Int J Radiat Oncol Biol Phys 2017 99 2 Suppl 1 E62 3 10.1016/j.ijrobp.2017.06.739Open DOISearch in Google Scholar

122Feng R, Oermann EK, Shrivastava R, Gold A, Collins BT, Kondziolka D, et al. Stereotactic radiosurgery for melanoma brain metastases: a comprehensive clinical case series. World Neurosurg 2017; 100: 297-304. doi: 10.1016/j.wneu.2017.01.014 Feng R Oermann EK Shrivastava R Gold A Collins BT Kondziolka D et al Stereotactic radiosurgery for melanoma brain metastases: a comprehensive clinical case series World Neurosurg 2017 100 297 304 10.1016/j.wneu.2017.01.01428093345Open DOISearch in Google Scholar

123Kaidar-Person O, Zagar TM, Deal A, Moschos SJ, Ewend MG, Sasaki-Adams D, et al. The incidence of radiation necrosis following stereotactic radiotherapy for melanoma brain metastases: the potential impact of immunotherapy. Anticancer Drugs 2017; 28: 669-75. doi: 10.1097/CAD.0000000000000497 Kaidar-Person O Zagar TM Deal A Moschos SJ Ewend MG Sasaki-Adams D et al The incidence of radiation necrosis following stereotactic radiotherapy for melanoma brain metastases: the potential impact of immunotherapy Anticancer Drugs 2017 28 669 75 10.1097/CAD.000000000000049728368903Open DOISearch in Google Scholar

124Minniti G, Paolini S, D’Andrea G, Lanzetta G, Cicone F, Confaloni V, et al. Outcomes of postoperative stereotactic radiosurgery to the resection cavity versus stereotactic radiosurgery alone for melanoma brain metastases. J Neurooncol 2017; 132: 455-62. doi: 10.1007/s11060-017-2394-z Minniti G Paolini S D’Andrea G Lanzetta G Cicone F Confaloni V et al Outcomes of postoperative stereotactic radiosurgery to the resection cavity versus stereotactic radiosurgery alone for melanoma brain metastases J Neurooncol 2017 132 455 62 10.1007/s11060-017-2394-z28260130Open DOISearch in Google Scholar

125Patel KR, Shoukat S, Oliver DE, Chowdhary M, Rizzo M, Lawson DH, et al. Ipilimumab and stereotactic radiosurgery versus stereotactic radiosurgery alone for newly diagnosed melanoma brain metastases. Am J Clin Oncol 2017; 40: 444-50. doi: 10.1097/COC.0000000000000199 Patel KR Shoukat S Oliver DE Chowdhary M Rizzo M Lawson DH et al Ipilimumab and stereotactic radiosurgery versus stereotactic radiosurgery alone for newly diagnosed melanoma brain metastases Am J Clin Oncol 2017 40 444 50 10.1097/COC.000000000000019926017484Open DOISearch in Google Scholar

126Pessina F, Navarria P, Tomatis S, Cozzi L, Franzese C, Di Guardo L, et al. Outcome evaluation of patients with limited brain metastasis from malignant melanoma, treated with surgery, radiation therapy, and targeted therapy. World Neurosurg 2017; 105: 184-90. doi: 10.1016/j.wneu.2017.05.131 Pessina F Navarria P Tomatis S Cozzi L Franzese C Di Guardo L et al Outcome evaluation of patients with limited brain metastasis from malignant melanoma, treated with surgery, radiation therapy, and targeted therapy World Neurosurg 2017 105 184 90 10.1016/j.wneu.2017.05.13128578123Open DOISearch in Google Scholar

127Sperduto PW, Jiang W, Brown PD, Braunstein S, Sneed P, Wattson DA, et al. The prognostic value of BRAF, C-KIT, and NRAS mutations in melanoma patients with brain metastases. Int J Radiat Oncol Biol Phys 2017; 98: 1069-77. doi: 10.1016/j.ijrobp.2017.03.030 Sperduto PW Jiang W Brown PD Braunstein S Sneed P Wattson DA et al The prognostic value of BRAF, C-KIT, and NRAS mutations in melanoma patients with brain metastases Int J Radiat Oncol Biol Phys 2017 98 1069 77 10.1016/j.ijrobp.2017.03.030692553128721890Open DOISearch in Google Scholar

128Xu Z, Lee CC, Ramesh A, Mueller AC, Schlesinger D, Cohen-Inbar O, et al. BRAF V600E mutation and BRAF kinase inhibitors in conjunction with stereotactic radiosurgery for intracranial melanoma metastases. J Neurosurg 2017; 126: 726-34. doi: 10.3171/2016.2.JNS1633 Xu Z Lee CC Ramesh A Mueller AC Schlesinger D Cohen-Inbar O et al BRAF V600E mutation and BRAF kinase inhibitors in conjunction with stereotactic radiosurgery for intracranial melanoma metastases J Neurosurg 2017 126 726 34 10.3171/2016.2.JNS163327203149Open DOISearch in Google Scholar

129Diao K, Bian SX, Routman DM, Yu C, Kim PE, Wagle NA, et al. Combination ipilimumab and radiosurgery for brain metastases: tumor, edema, and adverse radiation effects. J Neurosurg 2018; 129: 1397-406. doi: 10.3171/2017.7.JNS171286 Diao K Bian SX Routman DM Yu C Kim PE Wagle NA et al Combination ipilimumab and radiosurgery for brain metastases: tumor, edema, and adverse radiation effects J Neurosurg 2018 129 1397 406 10.3171/2017.7.JNS171286746998229303446Open DOISearch in Google Scholar

130Diao K, Bian SX, Routman DM, Yu C, Ye JC, Wagle NA, et al. Stereotactic radiosurgery and ipilimumab for patients with melanoma brain metastases: clinical outcomes and toxicity. J Neurooncol 2018; 139: 421-9. doi: 10.1007/s11060-018-2880-y Diao K Bian SX Routman DM Yu C Ye JC Wagle NA et al Stereotactic radiosurgery and ipilimumab for patients with melanoma brain metastases: clinical outcomes and toxicity J Neurooncol 2018 139 421 9 10.1007/s11060-018-2880-y746998129696531Open DOISearch in Google Scholar

131Fang P, Boehling NS, Koay EJ, Bucheit AD, Jakob JA, Settle SH, et al. Melanoma brain metastases harboring BRAF V600K or NRAS mutations are associated with an increased local failure rate following conventional therapy. J Neurooncol 2018; 137: 67-75. doi: 10.1007/s11060-017-2695-2 Fang P Boehling NS Koay EJ Bucheit AD Jakob JA Settle SH et al Melanoma brain metastases harboring BRAF V600K or NRAS mutations are associated with an increased local failure rate following conventional therapy J Neurooncol 2018 137 67 75 10.1007/s11060-017-2695-229198052Open DOISearch in Google Scholar

132Gabani P, Fischer-Valuck BW, Johanns TM, Hernandez-Aya LF, Keller JW, Rich KM, et al. Stereotactic radiosurgery and immunotherapy in melanoma brain metastases: patterns of care and treatment outcomes. Radiother Oncol 2018; 128: 266-73. doi: 10.1016/j.radonc.2018.06.017 Gabani P Fischer-Valuck BW Johanns TM Hernandez-Aya LF Keller JW Rich KM et al Stereotactic radiosurgery and immunotherapy in melanoma brain metastases: patterns of care and treatment outcomes Radiother Oncol 2018 128 266 73 10.1016/j.radonc.2018.06.01729960685Open DOISearch in Google Scholar

133Kano H, Morales-Restrepo A, Iyer A, Weiner GM, Mousavi SH, Kirkwood JM, et al. Comparison of prognostic indices in patients who undergo melanoma brain metastasis radiosurgery. J Neurosurg 2018; 128: 14-22. doi: 10.3171/2016.9.JNS161011 Kano H Morales-Restrepo A Iyer A Weiner GM Mousavi SH Kirkwood JM et al Comparison of prognostic indices in patients who undergo melanoma brain metastasis radiosurgery J Neurosurg 2018 128 14 22 10.3171/2016.9.JNS16101128106495Open DOISearch in Google Scholar

134Kotecha R, Miller JA, Venur VA, Mohammadi AM, Chao ST, Suh JH, et al. Melanoma brain metastasis: the impact of stereotactic radiosurgery, BRAF mutational status, and targeted and/or immune-based therapies on treatment outcome. J Neurosurg 2018; 129: 50-9. doi: 10.3171/2017.1.JNS162797 Kotecha R Miller JA Venur VA Mohammadi AM Chao ST Suh JH et al Melanoma brain metastasis: the impact of stereotactic radiosurgery, BRAF mutational status, and targeted and/or immune-based therapies on treatment outcome J Neurosurg 2018 129 50 9 10.3171/2017.1.JNS16279728799876Open DOISearch in Google Scholar

135Ladwa R, Atkinson V. The changing paradigm of management in melanoma brain metastases. Asia Pac J Clin Oncol 2018; 14: 453-8. doi: 10.1111/ajco.12998 Ladwa R Atkinson V The changing paradigm of management in melanoma brain metastases Asia Pac J Clin Oncol 2018 14 453 8 10.1111/ajco.1299829932306Open DOISearch in Google Scholar

136Matsunaga S, Shuto T, Yamamoto M, Yomo S, Kondoh T, Kobayashi T, et al. Gamma Knife radiosurgery for metastatic brain tumors from malignant melanomas: a Japanese multi-institutional cooperative and retrospective cohort study (JLGK1501). Stereotac Funct Neurosurg 2018; 96: 162-71. doi: 10.1159/000489948 Matsunaga S Shuto T Yamamoto M Yomo S Kondoh T Kobayashi T et al Gamma Knife radiosurgery for metastatic brain tumors from malignant melanomas: a Japanese multi-institutional cooperative and retrospective cohort study (JLGK1501) Stereotac Funct Neurosurg 2018 96 162 71 10.1159/00048994829969770Open DOISearch in Google Scholar

137Tio M, Wang X, Carlino MS, Shivalingam B, Fogarty GB, Guminski AD, et al. Survival and prognostic factors for patients with melanoma brain metastases in the era of modern systemic therapy. Pigment Cell Melanoma Res 2018; 31: 509-15. doi: 10.1111/pcmr.12682 Tio M Wang X Carlino MS Shivalingam B Fogarty GB Guminski AD et al Survival and prognostic factors for patients with melanoma brain metastases in the era of modern systemic therapy Pigment Cell Melanoma Res 2018 31 509 15 10.1111/pcmr.1268229277979Open DOISearch in Google Scholar

138Zubatkina I, Ivanov P. Early imaging radioresponsiveness of melanoma brain metastases as a predictor of patient prognosis. J Neurosurg 2018; 129: 354-65. doi: 10.3171/2017.1.JNS162075 Zubatkina I Ivanov P Early imaging radioresponsiveness of melanoma brain metastases as a predictor of patient prognosis J Neurosurg 2018 129 354 65 10.3171/2017.1.JNS16207528841116Open DOISearch in Google Scholar

139Jardim A, Scott J, Drew Z, Foote MC, Sadasivan AP, Hall B, et al. Extent of surrounding edema does not correlate with acute complications after radiosurgery for melanoma brain metastases. Neurooncol 2019; 145: 581-5. doi: 10.1007/s11060-019-03330-9 Jardim A Scott J Drew Z Foote MC Sadasivan AP Hall B et al Extent of surrounding edema does not correlate with acute complications after radiosurgery for melanoma brain metastases Neurooncol 2019 145 581 5 10.1007/s11060-019-03330-931691060Open DOISearch in Google Scholar

140Mastorakos P, Xu Z, Yu J, Hess J, Qian J, Chatrath A, et al. BRAF V600 mutation and BRAF kinase inhibitors in conjunction with Stereotactic radiosurgery for intracranial melanoma metastases: a multicenter retrospective study. Neurosurgery 2019; 84: 868-80. doi: 10.1093/neuros/nyy203 Mastorakos P Xu Z Yu J Hess J Qian J Chatrath A et al BRAF V600 mutation and BRAF kinase inhibitors in conjunction with Stereotactic radiosurgery for intracranial melanoma metastases: a multicenter retrospective study Neurosurgery 2019 84 868 80 10.1093/neuros/nyy203650544329846702Open DOISearch in Google Scholar

141Tjong MC, Moraes FY, Shultz D. Intracranial control and radionecrosis in melanoma patients with brain metastases treated with stereotactic radiosurgery. Radiother Oncol 2019; 139(Suppl 1): S59-60. doi: 10.1016/S0167-8140%2819%2933190-1 Tjong MC Moraes FY Shultz D Intracranial control and radionecrosis in melanoma patients with brain metastases treated with stereotactic radiosurgery Radiother Oncol 2019 139Suppl 1 S59 60 10.1016/S0167-8140%2819%2933190-1Open DOISearch in Google Scholar

142McHugh FA, Kow CY, Falkov A, Heppner P, Law A, Bok A, et al. Metastatic melanoma: surgical treatment of brain metastases - Analysis of 110 patients. J Clin Neurosci 2020; 73: 144-9. doi: 10.1016/j.jocn.2019.12.063 McHugh FA Kow CY Falkov A Heppner P Law A Bok A et al Metastatic melanoma: surgical treatment of brain metastases - Analysis of 110 patients J Clin Neurosci 2020 73 144 9 10.1016/j.jocn.2019.12.06331956087Open DOISearch in Google Scholar

143Pomeranz Krummel DA, Nasti TH, Izar B, Press RH, Xu M, Lowder L, et al. Impact of sequencing radiation therapy and immune checkpoint inhibitors in the treatment of melanoma brain metastases. Int J Radiat Oncol Biol Phys 2020; 108: 157-63. doi: 10.1016/j.ijrobp.2020.01.043 Pomeranz Krummel DA Nasti TH Izar B Press RH Xu M Lowder L et al Impact of sequencing radiation therapy and immune checkpoint inhibitors in the treatment of melanoma brain metastases Int J Radiat Oncol Biol Phys 2020 108 157 63 10.1016/j.ijrobp.2020.01.043783906032057994Open DOISearch in Google Scholar